Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
Higher BMI linked to increased cancer risk in those with cardiovascular disease
Higher BMI increased the risk for obesity-related cancer among a cohort of European adults, irrespective of cardiometabolic disease status, according to study results.
Joint statement calls for FDA to require drug trials to include people with obesity
Five obesity advocacy organization have issued a joint statement asking the FDA to mandate that all drug approval trials include people with obesity.
Log in or Sign up for Free to view tailored content for your specialty!
Visceral abdominal fat in midlife linked to Alzheimer’s disease
Having a higher amount of visceral abdominal fat in middle age was associated with an increased risk for developing Alzheimer’s disease, according to research presented at the annual meeting of the Radiological Society of North America.
Addressing pediatric obesity: The crucial role of parenting
Pediatric obesity has become a significant health concern in recent years, with the prevalence reaching higher levels. It is a complex condition influenced by various factors, including genetics, lifestyle choices and environmental factors.
Q&A: Study reveals income-based disparities for hypertension, obesity, diabetes
A study published in Annals of Internal Medicine revealed income-based disparities in diabetes, smoking and hypertension — findings that one expert called worrying.
Morning exercise linked to lower BMI, waist circumference for adults
Adults who exercise in the morning have a lower BMI and waist circumference than those who exercise in the afternoon or evening, according to study findings published in Obesity.
VIDEO: Deepak L. Bhatt, MD, MPH, highlights new data on semaglutide, tirzepatide at AHA
PHILADELPHIA — In this Healio exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.
Weight loss program led by advanced practice providers outperforms routine care in MASLD
BOSTON — An intensive, advanced practice provider-guided weight loss program helped patients with metabolic dysfunction-associated steatotic liver disease achieve statistically significant weight loss vs. standard of care.
Semaglutide cuts cardiovascular risk by 20% in people with heart disease, obesity: SELECT
PHILADELPHIA — In the SELECT trial, treatment with weekly injectable semaglutide 2.4 mg was superior to placebo for reducing cardiovascular risk in adults with preexisting heart disease and overweight or obesity but without diabetes.
Presenting weight loss in a positive way linked to greater treatment uptake
Weight loss presented as a positive opportunity by physicians was associated with greater uptake of treatment and weight loss, a study published in Annals of Internal Medicine found.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read